Neurogastroenterology and motilityHumansMetoclopramideFemaleMaleMiddle Aged
Revisiting the Incidence of Tardive Dyskinesia With Oral Metoclopramide Use: A Real-World Epidemiology Study (2011-2020).
Richard W McCallum, Henry P Parkman, Linda A Nguyen, Brenton A Wright, M Ammar Kalas, Chris Quesenberry, Ramaa Nathan, Mostafa Shokoohi, Jordan Donders, David C Kunkel
Published: 202610.1111/nmo.70206
Abstract
BACKGROUND: Gastroparesis is a debilitating disorder with limited treatment options, and metoclopramide remains the only FDA-approved pharmacologic therapy. Concerns about metoclopramide-induced tardive dyskinesia (TD) are based on older studies with…
Preview only. Read the full abstract at the source